Not Yet RecruitingPhase 2

Surgical Evacuation Versus Methotrexate Injection in Treatment of Caesarean Scar Pregnancy [Clinical Trial ]

42 participantsStarted 2026-01-20

Plain-language summary

The aim of the study is to compare the effectiveness and the complications of Ultrasound guided surgical evacuation versus using combined local and systemic methotrexate injection for management of caesarean scar pregnancy.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Gestation age Less than 12 weeks. Hemodynamically stable patient with un ruptured CSP. Non disturbed scar pregnancy . Acceptance of possible prolonged follow up, repeated HCG tests, the need for additional treatment doses and possible bleeding and subsequent hysterectomy. \- Exclusion Criteria: * Patient refuse TOP. Gestation age More than 12 weeks . Hemodynamically unstable patient with ruptured CSP. Contraindication for methotrexate as hepatic disorders, renal disorders ,hypersensitivity to the drug and autoimmune diseases.

What they're measuring

Success rate of treatment either by surgical evacuation or by methotrexate injection

Timeframe: Up to 8 weeks post -intervention

Trial details

NCT IDNCT07288307

SponsorMinia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01-20

Contact for this trial

Badr Atef AbdAllah, MD

+201092975253 dr.badratef@gmail.com

View on ClinicalTrials.gov More Caesarean Scar Pregnancy trials